Skip to content
Back to Guavy Wire
Stocks

Vioxx: A Drug That Killed 60,000 Americans

Instruments
MRK
Share

A little-known drug called Vioxx was prescribed to over 20 million Americans, leading to one of the largest pharmaceutical recalls in history. The painkiller, developed by Merck, was withdrawn from the market in 2004 after evidence showed it doubled the risk of heart attacks and strokes.

The story is told through a personal account of a former Navy buddy who recalled a conversation with his friends about Vioxx. They had never heard of the drug, despite being well-read and successful individuals.

Vioxx was approved by the FDA in May 1999 after a six-month 'priority review', which prioritized its perceived therapeutic advantage in reducing gastrointestinal side effects compared to older NSAIDs like naproxen.

The pre-approval clinical trials involved around 5,000 patients across eight to nine studies, but they were not designed to rigorously evaluate heart-related outcomes. The FDA's priority pathway expedited review was based on GI benefits, despite the limitations of the trials.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc